Home About Us Services Markets Resarch Online Trading Back Office Contact Us Download
Your are on :  Markets   |  News Analysis    |  Stock Alert   |Detailed News   
Back
HCL Tech, Cadila Healthcare, Glenmark Pharma in spotlight
21-Sep-21   08:36 Hrs IST

HCL Technologies announced a five-year, digital transformation deal with MKS Instruments Inc., a global provider of instruments, systems, subsystems and solutions for advanced manufacturing processes, to improve performance, productivity and speed to market.

Shares of SBI Cards and Payment Services will be in focus. CA Rover Holdings, an affiliate of Carlyle Asia may reportedly sell 3.2 crore shares in the company through a block trade. Shares are being offered at Rs 1,021 to Rs 1,072.3 each.

Zydus Healthcare, a wholly owned subsidiary of Cadila Healthcare has entered into an agreement with Integrace Private Limited ('Purchaser') to sell two brands viz. Mifegest and Cytolog.

Glenmark Pharmaceuticals (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Clindamycin Phosphate Foam, 1%, the generic version of Evoclin1 Foam, 1%, of Mylan Pharmaceuticals Inc.

Kitex Garments has signed the Memorandum of Understanding (MoU) with Telangana State Government for investing Rs. 2,406 crores in the state of Telangana. The investment is planned at Kakatiya Mega Textile Park, Warangal and Industrial Park, Sitarampur, Rangareddy District.

Action Construction Equipment launched its Qualified Institutions Placement on Monday. The floor price has been fixed at Rs 254.55 per share for the offer.

Powered by Capital Market - Live News

Product Disclaimer Mandatory Information Privacy Policy Careers Risk disclosures Feedback Scores Member Bank Details
"Investor Grievance" Mail your Grievance to info@lalkar.in Important Links:   SEBI  |  NSE  |  BSE  |  MCX-SX  |  MCX   |   NCDEX  |  NSDL  |  CDSL  |  FMC   |   CDSL E-Voting  |  SMART ODR
SEBI REGISTRATION NOS - BSE CASH: INZ000269434  |  BSE FNO: INZ000269434  |  NSE CASH: INZ000269434  |  NSE FNO: INZ000269434  |  NSE CD: INZ000269434  |  MSEI CASH: INZ000269434   |   MSEI FNO: INZ000269434   |   MSEI CD: INZ000269434
AMFI NO : ARN- 19226  |  LALKAR COMMODITIES PVT. LTD.: MCX: 10685 FMC: MCX/TCM/CORP/0655 | NSEL: 11300 | NCDEX: 1130 FMC No : NCDEX/TCM/CORP/1106
2010 © Lalkar Group. All rights reserved Designed, developed & powered by CMOTS Infotech(ISO 9001:2015 certified)